Zobrazeno 1 - 10
of 251
pro vyhledávání: '"Richard K, Valicenti"'
Autor:
Giulio Francolini, Michele Ganovelli, Vanessa Di Cataldo, Beatrice Detti, Saverio Caini, Mauro Loi, Gabriele Simontacchi, Isacco Desideri, Daniela Greto, Marianna Valzano, Sergio Serni, Luca Vaggelli, Viola Salvestrini, Luca Visani, Carlotta Becherini, Emanuela Olmetto, Ciro Franzese, Davide Baldaccini, Marta Scorsetti, Martina Sollini, Arturo Chiti, Icro Meattini, Richard K. Valicenti, Lorenzo Livi
Publikováno v:
Clinical & experimental metastasis, vol 40, iss 2
PSICHE (NCT05022914) is a prospective trial to test a [68Ga]Ga- PSMA-11 PET/CT imaging tailored strategy. All evaluable patients had biochemical relapse after surgery and underwent centralized [68Ga]Ga-PSMA-11 PET/CT imaging. The treatment was perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7c07e7fda156e6f3e519604bf13d958
https://escholarship.org/uc/item/26c8w6z0
https://escholarship.org/uc/item/26c8w6z0
Autor:
Jianfeng Qiu, Stanley H Benedict, Jyoti Mayadev, C. Wright, Yi Rong, Richard K. Valicenti, Liting Shi, Brandon A. Dyer, Zilong Yuan
Publikováno v:
Brachytherapy. 19:447-456
Purpose The purpose of this study is to evaluate the feasibility of using deformable image registration algorithms to improve high-dose-rate high-risk clinical target volume (HR-CTV) delineation between preapplicator implantation MRI (pre-MRI) and po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca887c3bbfcb04b358dc3a8c0c8393b1
https://doi.org/10.1016/j.brachy.2020.03.001
https://doi.org/10.1016/j.brachy.2020.03.001
Autor:
Jianfeng Qiu, Richard K. Valicenti, Brandon A. Dyer, Zilong Yuan, Jyoti Mayadev, Stanley H Benedict, Yi Rong
Publikováno v:
Brachytherapy. 18:378-386
Purpose To identify factors associated with MRI-to-CT image deformation accuracy and modes of failure for MRI-optimized intracavitary high-dose-rate treatment of locally advanced cervical cancer. Methods and Materials Twenty-six patients with locally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f36b317d5aa9c0f4e5d0fd0285548eb2
https://doi.org/10.1016/j.brachy.2019.01.001
https://doi.org/10.1016/j.brachy.2019.01.001
Autor:
Richard K. Valicenti, Felix Y. Feng, Eddy S. Yang, Matthew Parliament, J.M. Michalski, Daniel E. Spratt, Jean-Paul Bahary, Yuhchyau Chen, Harold Lau, A. Lenzie, D E Doncals, Mark V. Mishra, Luis Souhami, Lucas C. Mendez, Andrew M. McDonald, Lyudmila DeMora, H.M. Sandler, Mark D. Hurwitz, M. Roach, J. Hoyle
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e285-e286
PURPOSE/OBJECTIVE(S) To validate the association between body composition and all-cause mortality in men treated with radiation therapy for localized prostate cancer (PCa). Secondarily, to integrate body composition as a factor to help classify patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1652e8c0c4b55d57f095da8bcd8700d1
https://doi.org/10.1016/j.ijrobp.2021.07.911
https://doi.org/10.1016/j.ijrobp.2021.07.911
Autor:
F. Şen, Yasser Abdelhafez, Ramsey D. Badawi, Richard K. Valicenti, Mamta Parikh, Merin Stephen, M. Dall'Era, Xiaojun Julia Zhao, B.M. Usera, Simon R. Cherry, Lorenzo Nardo, Soheila Azghadi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e264-e265
Purpose/Objective(s) 18F-fluciclovine, an FDA-approved synthetic amino acid radiopharmaceutical for assessment of prostate cancer (PCa) recurrence, may show modest lesion detectability rates on conventional PET/CT scanners, especially for low PSA lev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adb55c3b1e20883b51cfe109efb1b65b
https://doi.org/10.1016/j.ijrobp.2021.07.867
https://doi.org/10.1016/j.ijrobp.2021.07.867
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e609-e610
PURPOSE/OBJECTIVE(S) The purpose of this study is to identify factors associated with severe late toxicity and prognosis in women with locally advanced cervical cancer treated with definitive chemoradiation (CRT) and high dose rate (HDR) radiation th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::299ead898e3176261ef3ca885c666807
https://doi.org/10.1016/j.ijrobp.2021.07.1625
https://doi.org/10.1016/j.ijrobp.2021.07.1625
Autor:
T M Schroeder, Louis Potters, Richard K. Valicenti, J. Kittel, Colleen A. Lawton, Mark K. Buyyounouski, Maroie Barkati, H.M. Sandler, M Mann, Stephanie L. Pugh, C E Duncan, J. Rodgers, D.C. Monitto, Rajat J. Kudchadker, J.M. Michalski, Ronald C. Chen, Eric Vigneault, Andre Konski, Omar Y. Mian, Raquibul Hannan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:S2-S3
Purpose/Objective(s) To determine if hypofractionated post-operative prostate bed radiotherapy (HYPORT) does not increase patient-reported genitourinary (GU) or gastrointestinal (GI) toxicity over conventionally fractionated post-operative radiothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d31b9f0e15f1952d1edb0ebae6639912
https://doi.org/10.1016/j.ijrobp.2021.07.041
https://doi.org/10.1016/j.ijrobp.2021.07.041
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e205-e206
PURPOSE/OBJECTIVE(S) For women with left-sided breast cancer, the most relevant side effect is collateral damage to the heart with radiation therapy. Prone treatment techniques have helped reduce heart dose, but is more unstable and difficult to repl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ac497dcafef65dd87e26b8bd1424a82
https://doi.org/10.1016/j.ijrobp.2021.07.729
https://doi.org/10.1016/j.ijrobp.2021.07.729
Publikováno v:
Therapeutic Advances in Urology, Vol 4 (2012)
Around 70% of men presenting with prostate cancer will have organ-confined disease, with the majority presenting with low- or intermediate-risk prostate cancer. This article reviews the evidence supporting the current standard of care in radiation on
Externí odkaz:
https://doaj.org/article/919cecc24b2d47cba9e04c48b2a29ac7
Autor:
Susan L. Stewart, Renee N. Donahue, Megan E. Daly, Sohelia Azghadi, Qian Chen, Shyam Rao, Ruben C Fragoso, Karen Kelly, Heather M. McGee, Arta M. Monjazeb, Leslie G. Oesterich, Robert J. Canter, Emanual Michael Maverakis, William J. Murphy, Jonathan D. Schoenfeld, Richard K. Valicenti, Jeffrey Schlom
Publikováno v:
International journal of radiation oncology, biology, physics, vol 101, iss 5
McGee, HM; Daly, ME; Azghadi, S; Stewart, SL; Oesterich, L; Schlom, J; et al.(2018). Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. International Journal of Radiation Oncology Biology Physics, 101(5), 1259-1270. doi: 10.1016/j.ijrobp.2018.04.038. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/8tk968p9
McGee, HM; Daly, ME; Azghadi, S; Stewart, SL; Oesterich, L; Schlom, J; et al.(2018). Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. International Journal of Radiation Oncology Biology Physics, 101(5), 1259-1270. doi: 10.1016/j.ijrobp.2018.04.038. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/8tk968p9
PurposeDespite the strong interest in combining stereotactic ablative radiation therapy (SAR) with immunotherapy, limited data characterizing the systemic immune response after SAR are available. We hypothesized that the systemic immune responseto SA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1deff49530a0a5ad4403be0bc83e879
https://doi.org/10.1016/j.ijrobp.2018.04.038
https://doi.org/10.1016/j.ijrobp.2018.04.038